Newtown, PA – November 24, 2015 – Susan C. Stein, MPH, CEO and Founder of the award-winning Connexion Healthcare, has been appointed to the Board of Directors of the National Comprehensive Cancer Network® (NCCN) Foundation along with Heather Kopecky, PhD, MBA, and Marc Samuels, JD, MPH. The NCCN Foundation advances the mission of the NCCN by funding important programs to give people affected by cancer the same information used by doctors, enabling those people to better understand the disease and make more informed decisions. Through donations from individuals, organizations, businesses, and foundations, the NCCN Foundation helps patients with cancer and caregivers navigate through screening, diagnosis, treatment, and beyond.
Connexion Healthcare, a full-service provider of medical and scientific communications, serves the world’s leading pharmaceutical, biotech, and medical device companies through its 2 Centers of Excellence — Oncology and Rare Disease. “Building awareness and educating healthcare professionals about cancer is at the core of Connexion Healthcare’s services. It is part of our mission and aligns perfectly with the goals of the NCCN Foundation. I look forward to contributing toward an even greater improvement in patient outcomes,” said Susan Stein.
Ms. Stein began her career in the pharmaceutical industry, continuing to the agency side before founding Connexion Healthcare. Ms. Stein also formed Connexion Cares, which serves as a vehicle to support healthcare research and foster patient advocacy. She is a member of the Drexel School of Public Health Dean’s Advisory Council, Member of the Global Genes Board of Directors, and Co-Chair for the 2016 Alex’s Lemonade Stand Foundation Lemon Ball. Ms Stein holds a Master of Public Health degree from Drexel University and a Bachelor of Science degree from the University of South Carolina.
About the NCCN
In 1993, the NCCN was formally incorporated to develop and institute standards of care for the treatment of cancer and perform outcomes research. With 13 original NCCN Member Institutions, its initial goal was to ensure delivery of high-quality, cost-effective services to people with cancer across the country. The NCCN became a developer and promoter of national programs to facilitate the fulfillment of NCCN Member Institution missions in education, research, and patient care. Now an alliance of 26 of the world’s leading cancer centers, the NCCN develops and communicates scientific, evaluative information to improve the quality, effectiveness, and efficiency of cancer care, so that patients can live better lives.